Fig. 7
From: Role of nuclear factor-kappa B in feline injection site sarcoma
DHMEQ inhibited migration of FISS cells. Wound healing assay in FISS-07. a Cell starved overnight (0.1% FBS) were used to generate wounds before DHMEQ treatment for 24 h. b Doses of 10 and 20 μg/ml DHMEQ were able to significantly reduce cell migration of FISS-07, FISS-08, and FISS-10 cells, respectively. *, statistically significant than controls (P < 0.05)